<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-27T04:50:04Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/18321" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/18321</identifier><datestamp>2026-02-03T12:01:35Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>New Approaches in the Manufacture of Biomaterials for Betalactam Allergic Diagnose</dc:title>
   <dc:creator>Collado-Martín, Daniel</dc:creator>
   <dc:creator>Pérez-de-Inestrosa-Villatoro, Ezequiel</dc:creator>
   <dc:creator>Ruiz-Sanchez, Antonio Jesus</dc:creator>
   <dc:creator>Mayorga Mayorga, Cristobalina</dc:creator>
   <dc:creator>Torres-Jaén, María Josefa</dc:creator>
   <dc:subject>Alergia a los medicamentos</dc:subject>
   <dcterms:abstract>Betalactams are the most widely utilized drugs against infections but are the primary cause of allergic reactions to&#xd;
antibiotic drugs. REF1 An accurate diagnosis of these allergic reactions to betalactams is crucial to avoid the use of&#xd;
unnecessary alternative antibiotics that may reduce efficacy, lead to prolonged treatments, have a higher toxicity or induce&#xd;
bacterial resistance. The most consensual approach to diagnose betalactam allergy are in vivo tests. However, they are not&#xd;
risky free, require experienced personnel and are both time-consuming and expensive for health-care systems, being so in&#xd;
vitro test more appropriate or complementary to the in vivo tests. In vitro tests are not still widely used on account of their&#xd;
low sensitivity. Current efforts are in progress to improve these assays, thus allowing for better diagnosis of allergic responses&#xd;
within patients. REF 2&#xd;
We report progress in the preparation of new functional materials for in vitro allergic diagnosis testing. In particular,&#xd;
the application of new approaches employing orthogonally functionalised fluorescent dyes based upon 4-amino-1,8&#xd;
naphthalimide joined with the multivalence of polyamide dendrimers. REF 3 The in vitro diagnosis capabilities of these&#xd;
functional materials was verified by testing on patient sera samples, with results demonstrating their potential for application&#xd;
within the healthcare industry.&#xd;
Acknowledgments: The present study has been supported by MINECO CTQ2016-75870P; by Andalusian Regional&#xd;
Ministry Health (grants: PI-0250-2016); by the European Regional Development Fund (ERDF) and “Plan Propio&#xd;
Universidad de Málaga” (UMA-Andalucía-TECH).</dcterms:abstract>
   <dcterms:dateAccepted>2019-09-11T12:33:53Z</dcterms:dateAccepted>
   <dcterms:available>2019-09-11T12:33:53Z</dcterms:available>
   <dcterms:created>2019-09-11T12:33:53Z</dcterms:created>
   <dcterms:issued>2019-09-11</dcterms:issued>
   <dc:type>conference output</dc:type>
   <dc:identifier>https://hdl.handle.net/10630/18321</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>5th World Congress on Electrical Engineering and Computer Systems and Sciences</dc:relation>
   <dc:relation>Lisboa</dc:relation>
   <dc:relation>22/08/2019</dc:relation>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>